New registry aims to unlock secrets of rare gynecologic condition
NCT ID NCT03564483
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a registry of 100 women with extramammary Paget's disease (EMPD) of the vulva or perianal area. Researchers will collect health information, tissue samples, and skin swabs to learn more about the disease and the bacteria living on affected skin. The goal is to better understand EMPD and track long-term outcomes, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRAMAMMARY PAGET DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New light treatment offers hope for rare vulvar cancer
- Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
- New virus therapy takes on advanced cancers in first human trial
- Immunotherapy duo takes on rare tumors
- Cancer-Fighting virus teams up with immunotherapy to tackle rare skin tumors